Do you want to read an article? Please log in or register.
A five-year retrospective study of the epidemiological characteristics and visual outcomes of pediatric ocular trauma
Further Publications
Related content
Uveitis
Uveitis in Juvenile Idiopathic Arthritis: 18-year Outcome in the Population-based Nordic Cohort Study
Ophthalmology.
Rypdal V, Glerup M, Songstad NT, Bertelsen G, Christoffersen T, Arnstad ED, Aalto K, Berntson L, Fasth A, Herlin T, Ekelund M, Peltoniemi S, Toftedal P, Nielsen S, Leinonen S, Bangsgaard R, Nielsen R, Rygg M, Nordal E, Nordic Study Group of Pediatric Rheumatology (NoSPeR).
doi: 10.1016/j.ophtha.2020.08.024.
Macular DiseasesRetinal Diseases
Baseline Predictors for Five-Year Visual Acuity Outcomes in the Comparison of AMD Treatment Trials
Ophthalmol Retina.
Ying GS, Maguire MG, Pan W, Grunwald JE, Daniel E, Jaffe GJ, Toth CA, Hagstrom SA, Martin DF; CATT Research Group
doi: 10.1016/j.oret.2017.10.003.
RECOMMENDED
LensesCataracts
5-year outcomes after primary intraocular lens implantation in children aged 2 years or younger with congenital or infantile cataract: findings from the IoLunder2 prospective inception cohort study
Lancet Child Adolesc Health.
Solebo AL, Cumberland P, Rahi JS; British Isles Congenital Cataract Interest Group
doi: 10.1016/S2352-4642
Retinal Diseases
Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study
Acta Ophthalmol
Stahl A, Bründer MC, Lagrèze WA, Molnár FE, Barth T, Eter N, Guthoff R, Krohne TU, Pfeil JM, CARE-ROP Study Group.
doi: 10.1111/aos.14852
Macular Diseases
Baseline visual acuity as a prognostic factor for visual outcomes in patients treated with aflibercept for wet age-related macular degeneration: data from the INSIGHT study using the Swedish Macula Register
Acta Ophthalmol.
Lövestam Adrian M, Vassilev ZP, Westborg I
doi: 10.1111/aos.13864.
RECOMMENDED
Cataracts
Visual Acuity and Ophthalmic Outcomes in the Year After Cataract Surgery Among Children Younger Than 13 Years
JAMA Ophthalmol.
Writing Committee for the Pediatric Eye Disease Investigator Group (PEDIG)., Repka MX, Dean TW, Kraker RT, Bothun ED, Morrison DG, Lambert SR, Stahl ED, Wallace DK
doi: 10.1001/jamaophthalmol.
COMMENTED
Retinal Diseases
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
JAMA Ophthalmol.
Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, Bressler NM, Elman MJ, Ferris FL 3rd, Gardner TW, Jampol LM, Martin DF, Melia M, Stockdale CR, Beck RW, Diabetic Retinopathy Clinical Research Network
doi: 10.1001/jamaophthalmol.
COMMENTED
Ocular Oncology
Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals
★ 3
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
doi: 10.1001/jamaophthalmol.2019.5132.
COMMENTED
Glaucoma and Ocular Pressure
Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up
★ 3
Recommended and commented by
Prof. Dr emer. Josef Flammer, Faculty Member
★ 2
Recommended by
Dr Katarzyna Konieczka, Faculty Member
JAMA Ophthalmol
Kass MA, Heuer DK, Higginbotham EJ, Parrish RK, Khanna CL, Brandt JD, Soltau JB, Johnson CA, Keltner JL, Huecker JB, Wilson BS, Liu L, Miller JP, Quigley HA, Gordon MO, Ocular Hypertension Study Group.
doi: 10.1001/jamaophthalmol.2021.0341